Evaluation of six risk factors for the development of bacteremia in children with cancer and febrile neutropenia

Current Oncology

Volumn 17, Issue 2, 2010, Pages 59-63

  Asturias, E J ^b,c   Corral, J E ^a   Quezada, J ^a  

^a Universidad Francisco Marroquin   (Guatemala)

^b Unidad Nacional de Oncologia Pediatrica   (Guatemala)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Bacteremia; C reactive protein; Cancer; Fever; Leukemia; Neutropenia; Risk factors; Thrombocytopenia

Indexed keywords

ANTIINFECTIVE AGENT; C REACTIVE PROTEIN; CEFTAZIDIME; CEPHALOSPORIN; CLINDAMYCIN; GENTAMICIN;

ADOLESCENT; ADULT; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; BACTERIAL GROWTH; BACTERIUM ISOLATION; CANCER CHEMOTHERAPY; CELLULITIS; CHILD; CLINICAL EVALUATION; CONTROLLED STUDY; DIARRHEA; FEBRILE NEUTROPENIA; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; INFANT; INTENSIVE CARE; LEUKEMIA RELAPSE; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; NEOPLASM; OTITIS MEDIA; RISK FACTOR; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 77950559031     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Tamburro R. Pediatric cancer patients in clinical trials of sepsis: factors that predispose to sepsis and stratify outcome. Pediatr Crit Care Med 2005;6(suppl):S87-91.
2. Pizzo PA. Fever in immunocompromised patients. N Engl J Med 1999;341:893-900.
3. Allen UD. Factors influencing predisposition to sepsis in children with cancers and acquired immunodeficiencies unrelated to human immunodeficiency virus infection. Pediatr Crit Care Med 2005;6(suppl):S80-6.
4. Santolaya ME, Alvarez AM, Becker A, et al. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. J Clin Oncol 2001;19:3415-21.
5. Castagnola E, Viscoli C, Bernaola E. Complicaciones infecciosas en el niño con enfermedad hematooncológica. In: Sierrasesúmaga L, Antillón Klussmann F, eds. Tratado de Oncología Pediátrica. Madrid: Pearson Educación S.A.; 2006: 755-84.
6. Velásquez M. Incidencia de Neutropenia Asociada al Tratamiento de Mantenimiento con 6 Mercaptopurina en Niños y Adolescentes de la Unidad de Oncología Pediátrica con Leucemia Linfoblástica Aguda [master's thesis]. Guatemala City, Guatemala: Facultad de Medicina, Universidad Francisco Marroquín; 2006: 5-16.
7. Santolaya ME, Alvarez AM, Avilés CL, et al. Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia. Clin Infect Dis 2002;35:678-83.
8. Hughes WT, Armstrong D, Bodey GP, et al. 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730-51.
9. Reinhart K, Meisner M, Brunkhorst FM. Markers for sepsis diagnosis: what is useful? Crit Care Clin 2006;22:503-19,ix-x.
10. Lyman GH. Risks and consequences of chemotherapy-induced neutropenia. Clin Cornerstone 2006;8(suppl 5):S12-18.
11. Lucas KG, Brown AE, Armstrong D, Chapman D, Heller G. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis. Cancer 1996;77:791-8.
12. Koçak U, Rolston KV, Mullen CA. Fever and neutropenia in children with solid tumors is similar in severity and out-come to that in children with leukemia. Support Care Cancer 2002;10:58-64.
13. Wojak I, Gospodarek E. Analysis of microorganisms isolated from febrile neutropenic children with neoplastic disease [Polish]. Med Dosw Mikrobiol 2004;56:411-19.
14. Duncan C, Chisholm JC, Freeman S, Riley U, Sharland M, Pritchard-Jones K. A prospective study of admissions for febrile neutropenia in secondary paediatric units in South East England. Pediatr Blood Cancer 2007;49:678-81.
15. Paganini H, Bologna R, Debbag R, et al. Fever and neutropenia in children with cancer in one pediatric hospital in Argentina. Pediatr Hematol Oncol 1998;15:405-13.
16. Aquino VM, Pappo A, Buchanan GR, Tkaczewski I, Mustafa MM. The changing epidemiology of bacteremia in neutropenic children with cancer. Pediatr Infect Dis J 1995;14:140-3.
17. Yilmaz S, Oren H, Demircioǧlu F, Irken G. Assessment of febrile neutropenia episodes in children with acute leukemia treated with bfm protocols. Pediatr Hematol Oncol 2008;25:195-204.
18. Greenberg D, Moser A, Yagupsky P, et al. Microbiological spectrum and susceptibility patterns of pathogens causing bacteraemia in paediatric febrile neutropenic oncology patients: comparison between two consecutive time periods with use of different antibiotic treatment protocols. Int J Antimicrob Agents 2005;25:469-73.
19. Feld R. Bloodstream infections in cancer patients with febrile neutropenia. Int J Antimicrob Agents 2008;32(suppl 1):S30-3.
20. Klaassen RJ, Goodman TR, Pham B, Doyle JJ. "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia. Clin Oncol 2000;18:1012-19.
21. Enrione M, Powell K. Sepsis, septic shock, and systemic inflammatory response syndrome. In: Kliegman R, Nelson WE, eds. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, PA: Saunders; 2007: chapter 176.